Results
90 patients were included. During the follow up period, (mean = 22
months; range = 6 - 59 months) cholesteatoma recidivism was observed in
2% of ears, (2 patients). An acceptably dry (Merchant Grade 0 – 1) ear
was achieved in 91% of all ears (95% Primary Cases, 80% Secondary
Cases). Delayed healing of the graft in the external ear canal retaining
the S53P4BAG Bioactive Glass (BonAlive,(BonAlive Biomaterials Ltd.,
Turku, Finland)) within the mastoid occurred in 13% (12 ears). However,
in all cases conservative management resulted in complete healing.